Cointime

Elicio Therapeutics

company

About

Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.

  • 1 - 10

Highlights

Total Funding Amount
$3.30M
Funding Rounds
1
Investors
1
Investments
9

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$3.30M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer. It offers potent vaccines and immunotherapies that enable precise targeting and delivery of immunogens directly to the lymphatic system, substantially enhancing the body's own system of immune defenses.

The company was founded in 2011 and is based in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.30M
Elicio Therapeutics has raised a total of $3.30M in funding over 2 rounds. Their latest funding was raised on Aug 3, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 3, 2012 Series Unknown $3.30M 1 Access BridgeGap Ventures — Detail

Investments

Number of Investments
Number of Lead Investments
9
0
Elicio Therapeutics has made 9 investments. Their most recent investment was on Dec 10, 2019, when GOSU Data Lab raised $2.80M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 10, 2019 GOSU Data Lab
Series B $2.80M Analytics —
Jan 1, 2019 XREX Inc.
Seed $7M Bitcoin —
Aug 23, 2016 Coda Payments
Series A $2M Digital Entertainment —
Dec 2, 2013 Coda Payments
Series A $2.30M Digital Entertainment —
Jul 17, 2013 RedMart
Series A — E-Commerce —
Show More

Investors

Number of Lead Investors
Number of Investors
1
1
Elicio Therapeutics is funded by 1 investors. Access BridgeGap Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Access BridgeGap Ventures Yes Series Unknown
Cointime
เนื้อหา
บริษัท